Comparison of sinusitis rate after sinus lift procedure and zygomatic implant surgery: a meta-analysis
Oral and Maxillofacial Surgery · 02.06.2023 · 28 (1) · 63-77
DOI: 10.1007/s10006-023-01159-1 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Oral and Maxillofacial Surgery, online erschienen am 02.06.2023. Verfasst von Roberta Schroder Rocha und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Cell and Molecular Biology, Cellular and Molecular Biology Department, Federal University of Paraná, Av. Cel. Francisco H. dos Sa…. Hauptthemen laut MEDLINE: Dental Implants, Sinus Floor Augmentation, Sinusitis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 70 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: To evaluate and compare the reported sinusitis occurrence after the sinus lift procedure and zygomatic implant placement. METHODS: This meta-analysis has been registered at PROSPERO. Studies were searched on six databases. Two authors screened titles and abstracts and fully analyzed the studies against the inclusion and exclusion criteria. The RoB 2.0 and the ROBINS-I tools were used to assess the quality and risk of bias of the included studies. The random-effects model was used for the meta-analysis. The prevalence of sinusitis was calculated based on the total of patients. Subgroup analysis was performed by sinus lift or zygomatic implant surgery technique. RESULTS: The search identified 2419 references. After applying the inclusion criteria, 18 sinus lift and 9 zygomatic implant placement studies were considered eligible. The pooled prevalence of sinusitis after sinus lift procedure was 1.11% (95% CI 0.30-2.28). The prevalence after zygomatic implant placement was 3.76% (95% CI 0.12-10.29). In the subgroup analysis, the lateral window approach showed a prevalence of sinusitis of 1.35% (95% CI 0.34-2.8), the transcrestal technique of 0.00% (95% CI 0.00-3.18), and the SALSA technique of 1.20% (95% CI 0.00-5.10). Regarding the techniques for zygomatic implant placement, the sinus slot technique showed a prevalence of 21.62% (95% CI 9.62-36.52) and the intrasinus technique of 4.36% (95% CI 0.33-11.08), and the prevalence after the extrasinus technique was 0.00% (95% CI 0.00-1.22). CONCLUSION: The sinusitis occurrence rate was higher after zygomatic implant placement than after sinus lift procedure and this occurrence was different depending on the used technique.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Program in Cell and Molecular Biology, Cellular and Molecular Biology Department, Federal University of Paraná, Av. Cel. Francisco H. dos Santos, 100, Paraná, 81530-000, Curitiba, Brazil. roschroder@hotmail.com.
- Independent research, Curitiba, Brazil.
- Straumann LLC, Irvine, United States of America.
- ILAPEO College, Curitiba, Brazil.
- Department of Cell Biology, Federal University of Parana, Curitiba, Brazil.
ORCID-Profile: Roberta Schroder Rocha, Camila Pereira Vianna, Larissa Carvalho Trojan, Luis Eduardo Marques Padovan
Zitieren
APA
Rocha, R. S., Vianna, C. P., Trojan, L. C., Padovan, L. E. M., & Dos Santos, M. C. G. L. (2023). Comparison of sinusitis rate after sinus lift procedure and zygomatic implant surgery: a meta-analysis. Oral and Maxillofacial Surgery, 28(1), 63-77. https://doi.org/10.1007/s10006-023-01159-1
Vancouver
Rocha RS, Vianna CP, Trojan LC, Padovan LEM, Dos Santos MCGL. Comparison of sinusitis rate after sinus lift procedure and zygomatic implant surgery: a meta-analysis. Oral and Maxillofacial Surgery. 2023;28(1):63-77. doi:10.1007/s10006-023-01159-1
BibTeX
@article{Rocha2023,
author = {Rocha, Roberta Schroder and Vianna, Camila Pereira and Trojan, Larissa Carvalho and Padovan, Luis Eduardo Marques and Dos Santos, Maria Cristina Godoy Leme},
title = {Comparison of sinusitis rate after sinus lift procedure and zygomatic implant surgery: a meta-analysis},
journal = {Oral and Maxillofacial Surgery},
year = {2023},
volume = {28},
number = {1},
pages = {63--77},
doi = {10.1007/s10006-023-01159-1}
}
EUVIMED